This is a working overview of deamidation, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-05-31 and is reviewed periodically as new material appears.
After a dried peptide is dissolved, the resulting solution is treated as a distinct material with its own stability profile. Temperature, pH, ionic strength, and peptide concentration all influence how long the solution remains suitable for its intended laboratory use. Some sequences are prone to oxidation, deamidation, or aggregation. Because these processes vary widely, no single storage condition applies to every peptide. Buffer composition and light exposure can also shift degradation rates.
Aseptic technique matters when the solution will contact cells or biological reagents. Working in a clean environment, using sterile liquids and containers, and minimizing open-vial time reduce the chance of microbial contamination. Filtration through a sterile filter can remove particles and microorganisms, but some filters adsorb peptides and some peptides are retained by certain membrane materials. Compatibility between the peptide, solvent, and filter should be checked when recovery is critical.
Once a peptide is dissolved, its solution is generally less stable than the dry powder. Chemical pathways such as hydrolysis, oxidation, and deamidation can alter the molecule, while physical processes can form aggregates or cause adsorption to container walls. The rate depends on pH, buffer composition, temperature, concentration, and the specific sequence. Aqueous stocks are therefore kept cold and used within a defined period. Stability testing is usually performed for each peptide rather than assumed from a general rule.
Cold storage slows most degradation but does not stop it. Reconstituted solutions are commonly divided into aliquots and held at -20 °C or -80 °C, depending on the peptide. Repeated freeze-thaw cycles can promote aggregation or precipitation, so single-use aliquots are preferred. Some peptides tolerate refrigeration for short intervals, while others require freezing immediately. Light-sensitive residues may need amber or foil-wrapped containers. The optimal condition remains peptide-specific and should be supported by stability data.
| Property | Value | Notes |
|---|---|---|
| Appearance after dissolution | Clear to slightly opalescent solution | Cloudiness or particles may indicate incomplete dissolution, aggregation, or contamination. |
| pH range for stability | Peptide-dependent | Many peptides are most stable near neutral pH, but some require acidic or slightly basic conditions. |
| Common preservative | None for many research uses | Antimicrobial preservatives can alter assays or react with peptides; use depends on application. |
| Typical container material | Borosilicate glass or low-binding plastic | Some peptides adsorb to plastic surfaces; siliconized or low-binding tubes can reduce loss. |
| Common quality check | RP-HPLC, LC-MS, UV absorbance | Identity, purity, and concentration are separate attributes; no single method measures all three. |
After a peptide is reconstituted, analytical checks can confirm identity, concentration, and purity. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry provides a mass value that supports sequence identity, while ultraviolet absorbance at 214 or 280 nanometers is often used for concentration estimation when the extinction coefficient is known. These methods answer different questions and are complementary. A single measurement rarely establishes full quality, because the same sample can appear acceptable by one method and fail another.
Concentration calculations depend on the amount of peptide present in the vial and the volume of solvent added. Lyophilized preparations often contain counterions, salts, or residual water, so the labeled mass may not equal the mass of the peptide itself. This difference can produce a calculated concentration that is higher than the true peptide concentration. Analytical determination of peptide content, rather than reliance on the vial label alone, reduces this source of error. Uncertainty in volume measurement also contributes, especially when small liquid volumes are handled.
Practical handling often includes dividing a reconstituted solution into single-use aliquots to limit freeze-thaw cycling. Vials made of low-binding plastic or glass with inert closures are common, and some protocols add a carrier protein or bulking agent to reduce adsorption. Filtration through a sterile filter may be used when a sterile solution is required, but filters can retain peptide if binding occurs. Mixing is usually gentle; vigorous vortexing can introduce air-liquid interfaces that promote aggregation. Each of these steps involves trade-offs between sterility, recovery, and analytical accuracy.
Storage recommendations for reconstituted peptides vary by sequence and intended use, so general rules remain broad. A common laboratory practice is to keep solutions cold, sometimes frozen, and protected from light, but freezing itself can damage certain peptides. The pH of the solution may be adjusted to a range where the peptide is most stable, though changing pH can also alter solubility. Documentation of reconstitution date, solvent, concentration, and storage conditions supports reproducibility. Stability data for a specific peptide are generally established by direct measurement rather than assumed from related compounds.
A fetus naturally acquires passive immunity from its mother during pregnancy. Maternal passive immunity is antibody-mediated immunity. The mother's antibodies (MatAb) are passed through the placenta to the fetus by an FcRn receptor on placental cells. This occurs around the third month of gestation. IgG is the only antibody isotype that can pass through the placenta. Passive immunity is also provided through the transfer of IgA antibodies found in breast milk that are transferred to the gut of a nursing infant, protecting against bacterial infections, until the newborn can synthesize its antibodies. Colostrum present in mothers milk is an example of passive immunity.
Tellurium-128 and -130 are essentially stable. They only decay by double beta decay, with half-lives >1020 years. They constitute the major fraction of natural occurring tellurium at 32 and 34% respectively. Tellurium-132 and its daughter 132I are important in the first few days after a criticality. It was responsible for a large fraction of the dose inflicted on workers at Chernobyl in the first week. The isobar forming 132Te/132I is: Tin-132 (half-life 40 s) decaying to antimony-132 (half-life 2.8 minutes) decaying to tellurium-132 (half-life 3.2 days) decaying to iodine-132 (half-life 2.3 hours) which decays to stable xenon-132. The creation of tellurium-126 is delayed by the long half-life (230 k years) of tin-126.
Forestal is a solvent used in chromatography, composed of acetic acid, water, and hydrochloric acid in a 30:10:3 ratio by volume. It is useful for isolating anthocyanins in room-temperature chromatography using standard filter paper.
Sources: en.wikipedia.org
The distinguished American scholar Richard Taruskin declared Adorno to be "preposterously overrated." The eminent pianist and critic Charles Rosen saw Adorno's book The Philosophy of New Music as "largely a fraudulent presentation, a work of polemic that pretends to be an objective study." Even a fellow Marxist such as the historian and jazz critic Eric Hobsbawm saw Adorno's writings as containing "some of the stupidest pages ever written about jazz." The British philosopher Roger Scruton saw Adorno as producing "reams of turgid nonsense devoted to showing that the American people are just as alienated as Marxism requires them to be, and that their cheerful life-affirming music is a 'fetishized' commodity, expressive of their deep spiritual enslavement to the capitalist machine." Irritation with Adorno's tunnel vision started even while he was alive. He may have championed Schoenberg, but the composer notably failed to return the compliment: "I have never been able to bear the fellow [...] It is disgusting, by the way, how he treats Stravinsky." Another composer, Luciano Berio, said in an interview, "It's not easy to completely refute anything that Adorno writes—he was, after all, one of the most acute, and also one of the most negative, intellects to excavate the creativity of the past 150 years...
The compounds targeted in this manner by GSTs encompass a diverse range of environmental or otherwise exogenous toxins, including chemotherapeutic agents and other drugs, pesticides, herbicides, carcinogens, and variably-derived epoxides; indeed, GSTs are responsible for the conjugation of β1-8,9-epoxide, a reactive intermediate formed from aflatoxin B1, which is a crucial means of protection against the toxin in rodents. The detoxification reactions comprise the first four steps of mercapturic acid synthesis, with the conjugation to GSH serving to make the substrates more soluble and allowing them to be removed from the cell by transporters such as multidrug resistance-associated protein 1 (MRP1). After export, the conjugation products are converted into mercapturic acids and excreted via the urine or bile. Most mammalian isoenzymes have affinity for the substrate 1-chloro-2,4-dinitrobenzene, and spectrophotometric assays utilising this substrate are commonly used to report GST activity. However, some endogenous compounds, e.g., bilirubin, can inhibit the activity of GSTs. In mammals, GST isoforms have cell specific distributions (for example, α-GST in hepatocytes and π-GST in the biliary tract of the human liver). GSTs have a role in the bioactivation process of clopidogrel prodrug.
This is problematic long-term and can lead to ACTH-receptor pathway-related side effects including: Cushing's syndrome, fluid retention, glaucoma, and cardiovascular disorders. Mutations in this receptor cause familial glucocorticoid deficiency (FGD) type 1, in which patients have high levels of serum ACTH and low levels of cortisol. Mutation of the receptor gene causes 25% of FGD, and mutation on the MRAP gene causes 20% of FGD. Mutations of ACTH can also contribute to this pathology: mutation of the "message sequence" inhibits cAMP production when bound to the ACTH receptor, and mutation of the "address sequence" inhibits binding to the receptor altogether.
Sources: en.wikipedia.org
Most reconstituted peptide solutions are kept cold, often at 2–8 °C for short-term use. Longer storage may require freezing at -20 °C or below, depending on the peptide. Repeated freeze-thaw cycles can promote aggregation or degradation.
Freezing concentrates solutes and can expose peptides to ice interfaces, which may unfold or aggregate some sequences. Repeated cycles amplify these stresses. Aliquoting before freezing reduces the number of cycles a single container experiences.
Yes. Some membrane filters bind peptides, especially hydrophobic or positively charged sequences, reducing the amount recovered. Filter material and pore size should be selected with compatibility in mind. Recovery can be checked by comparing pre- and post-filtration analysis when needed.
No single time applies to all peptides. Storage life depends on sequence, solvent, concentration, and temperature. Stability should be determined experimentally or taken from supplier data for the specific lot.